Results 111 to 120 of about 1,032,308 (279)
The Psychopharmacology of Novel Synthetic Cannabinoids [PDF]
, 2017 Over recent years, the rapid proliferation of novel psychoactive substances has presented significant challenges to health professionals, regulators, and forensic scientists alike.
Kevin, Richard Charles
core
Synthetic cannabinoids: the hidden side of Spice drugs
, 2017 Spice drugs are herbal mixtures sprayed with synthetic cannabinoids designed to mimic the psychoactive ingredient in marijuana [Δ9-tetrahydrocannabinol (Δ9-THC)] and synthesized by introducing modifications to the chemical structure of parental compounds
Pintori N. +5 more
core +1 more source
Addiction, EarlyView.Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke +5 more
wiley +1 more source
Cryptogenic stroke in young patients and cannabis use: case presentation and literature review
Neurologijos seminarai, 2019 Approximately 10% of ischemic strokes occur in people under the age of 50 – this is called early on set or stroke in young adults. In this patient population, there is an especially high number of cryptogenic strokes, where etiology is not identified or
A. Atkočiūnas +4 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Since their emergence on the drug market, synthetic cannabinoids (SC) are still gaining increasing importance in forensic toxicology. The representatives of the so‐called new psychoactive substances have in common that they have not undergone preclinical safety studies. Hence, knowledge on toxicokinetic (TK) data is sparse.
Adrian A. Doerr +10 more
wiley +1 more source
Further consideration of the synthetic cannabinoids. [PDF]
, 2012 Report from the ACMD to the UK Home Secretary regarding synthetic cannabinoids. In July 2009 the Advisory Council on the Misuse of Drugs (ACMD) provided advice on harmful synthetic compounds (synthetic cannabinoid receptor agonists).
core
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
British Journal of Pharmacology, EarlyView.Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli +7 more
wiley +1 more source
The strength of your cannabinoid may be higher than you think. Synthetic Cannabinoids (‘Spice’). [PDF]
, 2017 Synthetic cannabinoids can mimic the effects of cannabis and can cause extreme agitation and ...
core
Novel approaches for drug development against chronic primary pain: A systematic review
British Journal of Pharmacology, EarlyView.Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Journal of Acute DiseaseRationale: Synthetic cannabinoids are increasingly used as recreational drugs and have been associated with adverse cardiovascular effects. However, reports of synthetic cannabinoids accompanied by constrictive pericarditis are limited. Patient’s concern:
Mahsa Behnemoon +4 more
doaj +1 more source